Alsachim renews its ISO 13485 certification 03.09.2024

Alsachim renews its ISO 13485 certification

Alsachim has obtained the renewal of its ISO 13485 certification for its activity as a manufacturer of in vitro medical devices. The renewal of this certification is recognition of our [...]

Amphotericin B: develoment of an internal standard for LC/MS analysis 12.03.2024

Amphotericin B: develoment of an internal standard for LC/MS analysis

Understanding the challenges of antifungal agents, Alsachim has applied its know-how to provide the first labeled internal standard of Amphotericin B on the market. Indeed, this antifungal [...]

Two events to meet! 09.05.2023

Two events to meet!

This May, we are taking part in international events! Meet our team and discover how Alsachim can support you and your projects. We are looking forward to meeting you there!   IIS-ED 26th [...]

Lenacapavir, a new hope for the treatment of AIDS 28.02.2023

Lenacapavir, a new hope for the treatment of AIDS

Alsachim is proud to add the [13C,2H3]-Lenacapavir labeled standard to its product catalogue. This new antiretroviral is the outcome of a strong R&D and synthesis work done by Alsachim teams. A [...]

International Day of Women & Girls in Science 13.02.2023

International Day of Women & Girls in Science

The 11th February 2023, we celebrate Women and Girls in Science. It’s important to acknowledge the role of women in science, the positive change they bring and their crucial contribution to sc [...]

Alsachim supports the fight against malaria 27.01.2023

Alsachim supports the fight against malaria

Among its collaborations across the world, Alsachim is proud to support the WorldWide Antimalarial Resistance Network (WWARN), the malaria platform of the Infectious Diseases Data Observatory. [...]